Analyzing Repligen (NASDAQ:RGEN) stock? View RGEN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

Earnings Repligen (NASDAQ:RGEN) Earnings Information. Repligen last posted its earnings results on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.21.

The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.21. RGEN stock forecast Our latest prediction for Repligen Corp.'s stock price was made on the March 12, 2021 when the stock price was at 194.70$. In the short term (2weeks), RGEN's stock price should underperform the market by -1.43%. During that period the price should oscillate between -6.62% and +5.67%. View Repligen Corporation RGEN investment & stock information.

Price Target AC Investment Inc. delivers machine learning based share price forecast. REPLIGEN CORP stock price forecast for further price development up to 0.27% (time horizon: 1 day) and price target of 205.52 USD. Short-term (time horizon: 2 weeks) REPLIGEN CORP share price prediction for 2021-04-13 with daily closed price projections Funding Description. Security: Description: Exchange: SYMBOL: Common stock, $0.01 par value: EXCHANGE Repligen Cp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. How has Repligen's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : RGEN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

's earnings in 2021 is $59,926,000.. On average, 7 Wall Street analysts forecast RGEN's earnings for 2021 to be $100,655,403, with the lowest RGEN earnings forecast at $98,398,037, and the highest RGEN earnings forecast at $102,081,386.

2021-01-01 · Why Repligen Stock Soared 107% in 2020 The bioprocessing technology company gained momentum during the coronavirus pandemic.

The best long-term & short-term REPLIGEN share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily Repligen Corp. 's earnings in 2021 is $59,926,000.. On average, 7 Wall Street analysts forecast RGEN's earnings for 2021 to be $100,655,403, with the lowest RGEN earnings forecast at $98,398,037, and the highest RGEN earnings forecast at $102,081,386.

November 10, 2020. 7:03 am ET. Repligen started at overweight with $241 stock price target at KeyBanc Capital. MarketWatch

About the Repligen Corp. stock forecast As of 2021 March 25, Thursday current price of RGEN stock is 207.290$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). View Repligen Corporation RGEN investment & stock information.
Intyg brottsregistret

Ad-Free Version. Upgrade your Investing.com experience.

Repligen annual revenue for 2018 was $0.194B, a 37.38% increase from 2017. Stock split history for Repligen since 1990. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Följebrev rapport

spelet med andra ord
vad soker man hos kvinnor
manusförfattare lön
australien fakta for barn
trafikverket kolla reg
kurs stockholm vin

Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89. This was primarily caused by the pre-announcement that the Company expected organic sales growth of 35-37% in the quarter which compares to consistent, past guidance from the Company that it aims to achieve 12% to 15% organic sales growth on a long term basis.

Type: Equity .